These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 236061)

  • 1. Brom-ergocryptine in the treatment of phenothiazine-induced galactorrhoea.
    Beumont P; Bruwer J; Pimstone B; Vinik A; Utian W
    Br J Psychiatry; 1975 Mar; 126():285-8. PubMed ID: 236061
    [No Abstract]   [Full Text] [Related]  

  • 2. Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154).
    Lloyd SJ; Josimovich JB; Archer DF
    Am J Obstet Gynecol; 1975 May; 122(1):85-9. PubMed ID: 1168997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
    Seki K; Seki M; Okumura T
    Acta Endocrinol (Copenh); 1975 May; 79(1):25-33. PubMed ID: 1173307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
    Dickey RP; Stone SC
    Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine.
    Besser GM; Parke L; Edwards CR; Forsyth IA; McNeilly AS
    Br Med J; 1972 Sep; 3(5828):669-72. PubMed ID: 4675488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and hormonal response to bromocriptin (CB-154) in the galactorrhea syndromes.
    Del Pozo E; Varga L; Wyss H; Tolis G; Friesen H; Wenner R; Vetter L; Uettwiler A
    J Clin Endocrinol Metab; 1974 Jul; 39(1):18-26. PubMed ID: 4209685
    [No Abstract]   [Full Text] [Related]  

  • 7. Bromocryptine therapy in cases of amenorrhea-galactorrhea.
    Mroueh AM; Siler-Khodr TM
    Am J Obstet Gynecol; 1977 Feb; 127(3):291-8. PubMed ID: 576372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine dysfunction in galactorrhea-amenorrhea after oral contraceptive use.
    Tyson JE; Andreasson B; Huth J; Smith B; Zacur H
    Obstet Gynecol; 1975 Jul; 46(1):1-11. PubMed ID: 1153129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cyclic gonadotropin secretion by endogenous human prolactin.
    Tyson JE; Khojandi M; Huth J; Smith B; Thomas P
    Am J Obstet Gynecol; 1975 Feb; 121(3):375-9. PubMed ID: 1115151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of prolactin in disturbances of the menstrual cycle].
    Wenner R
    Gynecologie; 1974; 25(2):229-31. PubMed ID: 4448266
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of brom-ergocryptine in treating amenorrhea/galactorrhea.
    Shapiro AG
    South Med J; 1977 Jun; 70(6):720-1, 725. PubMed ID: 577621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Response to the treatment of non-puerperal galactorrhea with dihydroergotoxine (author's transl)].
    Zielinski de Jakubowicz D; Obregón O
    Acta Cient Venez; 1979; 30(1):98-104. PubMed ID: 121905
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of galactorrhoea and amenorrhoea and subsequent restoration of ovarian function by a new ergot alkaloid 2-brom-alpha-ergocryptine.
    Rolland R; Schellekens LA; Lequin RM
    Clin Endocrinol (Oxf); 1974 Apr; 3(2):155-66. PubMed ID: 4858165
    [No Abstract]   [Full Text] [Related]  

  • 14. [2-bromo-alpha-ergocryptine in the treatment of luteal insufficiency].
    Nappi C; Votino F; Mattera P; Montemagno U
    Minerva Ginecol; 1979 Apr; 31(4):273-80. PubMed ID: 572516
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical response of patients with galactorrhea to pergolide, a potent, long-acting dopaminergic ergot derivative.
    Callaghan JT; Cleary RE; Crabtree R; Lemberger L
    Life Sci; 1981 Jan; 28(1):95-102. PubMed ID: 7194408
    [No Abstract]   [Full Text] [Related]  

  • 16. Predicted ovulatory response to 2-brom-alpha-ergocryptine (CB-154) in amenorrhea-galactorrhea syndromes.
    Shewchuk AB; Corenblum B; Pairaudeau N; Ezrin C; Adamson GD
    Am J Obstet Gynecol; 1980 Mar; 136(5):652-8. PubMed ID: 7188835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa in Forbes-Albright syndrome.
    Flückiger E; Del Pozo E
    Can Med Assoc J; 1973 Mar; 108(5):554. PubMed ID: 4689553
    [No Abstract]   [Full Text] [Related]  

  • 18. Ergot treatment of nonpuerperal galactorrhea.
    N Engl J Med; 1972 Oct; 287(14):723. PubMed ID: 5055426
    [No Abstract]   [Full Text] [Related]  

  • 19. Pregnancy following 2-bromo-alpha-ergocryptine (CB-154)-induced ovulation in an acromegalic patient with galactorrhea and amenorrhea.
    Aono T; Shioji T; Kohno M; Ueda G; Kurachi K
    Fertil Steril; 1976 Mar; 27(3):341-4. PubMed ID: 943332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of response to ergocryptine in the galactorrhea-amenorrhea syndrome.
    Corenblum B; Taylor PJ
    Fertil Steril; 1978 Oct; 30(4):388-92. PubMed ID: 581377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.